Pilot trial of amlodipine/celecoxib [KIT-302] in patients with hypertension
Phase of Trial: Phase I
Latest Information Update: 10 May 2016
At a glance
- Drugs Amlodipine/celecoxib (Primary) ; Amlodipine; Celecoxib
- Indications Hypertension
- Focus Pharmacokinetics
- 10 May 2016 According to Kitov media release, company will submit NDA to the FDA at the end of this year and anticipated marketing approval in 2017. Results from this study has fulfilled the FDA standard for demonstrating bioequivalence under both fed and fasted conditions.
- 10 May 2016 Results published in Kitov media release.
- 10 May 2016 Status changed from planning to completed, as per Kitov media release.